Document Detail


Impaired Role of Epoxyeicosatrienoic Acids in the Regulation of Basal Conduit Artery Diameter During Essential Hypertension.
MedLine Citation:
PMID:  23090775     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
In young healthy subjects, epoxyeicosatrienoic acids synthesized by endothelial cytochrome P450 epoxygenases maintain basal conduit artery diameter during altered NO availability. Whether this compensatory mechanism is effective during essential hypertension is unknown. Radial artery diameter, blood flow, and mean wall shear stress were determined in 14 nontreated essential hypertensive patients and 14 normotensive control subjects during 8 minutes of brachial infusion for inhibitors of cytochrome P450 epoxygenases (fluconazole, 0.4 µmol/min) and NO synthase (N(G)-monomethyl-l-arginine, 8 µmol/min) alone and in combination. In controls, the radial artery diameter was reduced by fluconazole (-0.034 ± 0.012 mm) and N(G)-monomethyl-l-arginine (-0.037 ± 0.010 mm) and to a larger extent by their combination (-0.137 ± 0.011 mm), demonstrating a synergic effect. In contrast, the radial diameter in hypertensive patients was not affected by fluconazole (0.010 ± 0.014 mm) but was reduced by N(G)-monomethyl-l-arginine (-0.091 ± 0.008 mm) to a larger extent than in controls. In parallel, N(G)-monomethyl-l-arginine decreased local plasma nitrite to a lesser extent in hypertensive patients (-14 ± 5 nmol/L) than in controls (-50 ± 10 nmol/L). Moreover, the addition of fluconazole to N(G)-monomethyl-l-arginine did not further decrease radial diameter in patients (-0.086 ± 0.011 mm). Accordingly, fluconazole significantly decreased local epoxyeicosatrienoic acid plasma level in controls (-2.0 ± 0.6 ng/mL) but not in patients (-0.9 ± 0.4 ng/mL). Inhibitors effects on blood flow and endothelium-independent dilatation to sodium nitroprusside were similar between groups. These results show that, in contrast to normotensive subjects, epoxyeicosatrienoic acids did not contribute to the regulation of basal conduit artery diameter and did not compensate for altered NO availability to maintain this diameter in essential hypertensive patients.
Authors:
Jeremy Bellien; Isabelle Remy-Jouet; Michele Iacob; Etienne Blot; Alain Mercier; Daniele Lucas; Yvonne Dreano; Laurence Gutierrez; Nathalie Donnadieu; Christian Thuillez; Robinson Joannides
Related Documents :
24840155 - Mechanics and composition of middle cerebral arteries from simulated microgravity rats ...
14716545 - Burst strength of laparoscopic and open hernia repair.
9687835 - Indications for peripartum aortic pressure monitoring in takayasu's disease. a patient ...
19942845 - Hypertension in aortic coarctation.
3668845 - Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog.
22447975 - Surgical optimization and characterization of a minimally invasive aortic banding proce...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-22
Journal Detail:
Title:  Hypertension     Volume:  -     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Departments of Pharmacology and Pharmacy and Centre d'Investigation Clinique-Institut National de la Sante et de la Recherche Medicale 0204, Rouen University Hospital, Rouen, France; Institut National de la Sante et de la Recherche Medicale U1096, Rouen, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cafeteria diet increases fat mass and chronically elevates lumbar sympathetic nerve activity in rats...
Next Document:  Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia.